Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| TANOX INC | 3,661,879 | reported | 06 Nov 2006 | tx 40+4,035,983−4,077,269 |
| W&T OFFSHORE INC | 112,652 | reported | 03 Jun 2025 | tx 7+328,752−112,652 |
| Galera Therapeutics, Inc. | 96,000 | reported | 24 Feb 2025 | tx 3+7,742,773.92 |
| Immix Biopharma, Inc. | 12,500 | reported | 22 May 2026 | tx 3+58,393 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 10,710 | reported | 07 May 2010 | tx 12+78,160 |
| SCICLONE PHARMACEUTICALS INC | 0 | reported | 13 Oct 2017 | tx 20+255,040−225,040 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 22 May 2026 | GRANT_AWARD | Immix Biopharma, Inc. | 6,250 | 0.00 USD | |
| 22 May 2026 | GRANT_AWARD | Immix Biopharma, Inc. | 12,500 | 0.00 USD | deriv |
| 21 Nov 2025 | GRANT_AWARD | Immix Biopharma, Inc. | 39,643 | 0.00 USD | deriv |
| 03 Jun 2025 | EXERCISE | W&T OFFSHORE INC | 73,892 | — | |
| 03 Jun 2025 | EXERCISE | W&T OFFSHORE INC | 73,892 | 0.00 USD | deriv |
| 03 Jun 2025 | GRANT_AWARD | W&T OFFSHORE INC | 103,448 | 0.00 USD | deriv |
| 24 Feb 2025 | GRANT_AWARD | Galera Therapeutics, Inc. | 96,000 | 0.00 USD | deriv |
| 30 Dec 2024 | PURCHASE | Galera Therapeutics, Inc. | 7,644,932 | 0.07 USD | first after silence |
| 30 Dec 2024 | GRANT_AWARD | Galera Therapeutics, Inc. | 1,841.92 | 0.00 USD | deriv |
| 17 Jun 2024 | EXERCISE | W&T OFFSHORE INC | 38,760 | — | |
| 14 Jun 2024 | GRANT_AWARD | W&T OFFSHORE INC | 73,892 | 0.00 USD | deriv |
| 17 Jun 2024 | EXERCISE | W&T OFFSHORE INC | 38,760 | 0.00 USD | deriv |
| 03 Jul 2023 | GRANT_AWARD | W&T OFFSHORE INC | 38,760 | 0.00 USD | deriv |
| 13 Oct 2017 | OTHER | SCICLONE PHARMACEUTICALS INC | 70,000 | 11.18 USD | |
| 13 Oct 2017 | OTHER | SCICLONE PHARMACEUTICALS INC | 30,000 | 2.03 USD | deriv |
| 13 Oct 2017 | OTHER | SCICLONE PHARMACEUTICALS INC | 30,000 | 0.28 USD | deriv |
| 08 Jun 2017 | GRANT_AWARD | SCICLONE PHARMACEUTICALS INC | 30,000 | 0.00 USD | deriv |
| 29 Sept 2016 | EXERCISE | SCICLONE PHARMACEUTICALS INC | 33,333 | 5.22 USD | |
| 29 Sept 2016 | EXERCISE | SCICLONE PHARMACEUTICALS INC | 7,648 | 5.10 USD | |
| 29 Sept 2016 | EXERCISE | SCICLONE PHARMACEUTICALS INC | 7,648 | 0.00 USD | deriv |
| 29 Sept 2016 | EXERCISE | SCICLONE PHARMACEUTICALS INC | 33,333 | 0.00 USD | deriv |
| 29 Aug 2016 | SALE | SCICLONE PHARMACEUTICALS INC | 10,000 | 10.31 USD | anomaly |
| 30 Aug 2016 | SALE | SCICLONE PHARMACEUTICALS INC | 7,540 | 10.33 USD | |
| 26 Aug 2016 | SALE | SCICLONE PHARMACEUTICALS INC | 7,500 | 10.25 USD | |
| 09 Jun 2016 | GRANT_AWARD | SCICLONE PHARMACEUTICALS INC | 30,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 30 Dec 2024.